Our InVision® platform unlocks essential genomic information from a simple blood draw to transform the care of cancer patients
We are transforming the lives of cancer patients and their families through the power of liquid biopsy
Latest News and Events
Funds will accelerate clinical development of RaDaR minimal residual disease assay and commercialization of InVisionFirst®-Lung Read More
Circulating tumor DNA (ctDNA) clearance as a biomarker in patients with locally advanced NSCLC following chemoradiation
B. Knapp, L. Mezquita, S. Devarakonda, M. Aldea, S. Waqar, K. Pepin, J. Ward, A. Botticella, K. Howarth, C. Knape, C. Morris, R. ... Read More
Patients are at the heart of everything we do.
Our first product is for advanced Non-Small Cell lung Cancer and our world-leading tests are already impacting patients’ lives.
This is the story of the first patient Inivata tested.